Prosperity Capital Advisors’s Boston Scientific BSX Stock Holding History

Prosperity Capital Advisors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$204K	Buy	4,772 +46	+1%	+$2.5K	0.01%	411
2026 Q1	$297K	Sell	4,726 -30	-0.6%	-$2.4K	0.02%	333
2025 Q4	$453K	Sell	4,756 -20	-0.4%	-$1.96K	0.03%	262
2025 Q3	$466K	Buy	4,776 +121	+3%	+$12.5K	0.03%	285
2025 Q2	$500K	Buy	4,655 +81	+2%	+$8.2K	0.03%	261
2025 Q1	$463K	Buy	4,574 +631	+16%	+$63.5K	0.04%	241
2024 Q4	$352K	Buy	3,943 +50	+1%	+$4.4K	0.03%	263
2024 Q3	$326K	Buy	+3,893	New	+$307K	0.03%	263

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Prosperity Capital Advisors's BSX Position: Q2 2026 in Review

Prosperity Capital Advisors increased its Boston Scientific (BSX) stake by 0.97% in Q2 2026, buying an estimated $2.5K and bringing the position to 4,772 shares worth $204K. The position accounts for 0.01% of the portfolio, ranked #411.

Prosperity Capital Advisors first reported a position in BSX in Q3 2024 and has held it in 8 quarters since. The position peaked at $500K in Q2 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Prosperity Capital Advisors held 4,772 shares of Boston Scientific worth $204K as of Q2 2026.
Prosperity Capital Advisors bought 46 Boston Scientific shares in Q2 2026, an estimated $2.5K.
Boston Scientific made up 0.01% of Prosperity Capital Advisors's portfolio in Q2 2026, its #411 holding.
Prosperity Capital Advisors first reported a position in Boston Scientific in Q3 2024 and has held it in 8 quarters since.
Prosperity Capital Advisors's Boston Scientific position peaked at $500K in Q2 2025.
1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Prosperity Capital Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.